Answers are grounded in this paper and cite their sources.
Background CT pulmonary angiography (CTPA) is commonly used to investigate suspected pulmonary embolism (PE) during pregnancy, but institutional radiation-dose benchmarks are limited. This study evaluated CTPA dose metrics and proposed institutional diagnostic reference levels (IDRLs) in pregnant patients. Methods This retrospective single-centre study included 120 consecutive pregnant patients who underwent CTPA for suspected PE over a 10-year period (from October 2016 to March 2026). CTDIvol and dose–length product (DLP) were reported. IDRLs were defined as the 75th percentiles of dose distributions. Effective dose was estimated as DLP × 0.014 mSv·mGy −1 ·cm −1 . Nonparametric analyses evaluated associations with patient, acquisition, trimester, and temporal variables. Results Mean maternal age was 33.53 ± 6.78 years. Six examinations (5.0%) were positive for PE. Mean CTDIvol and DLP were 12.15 ± 4.30 mGy and 307.89 ± 123.89 mGy·cm, respectively, corresponding to an estimated effective dose of 4.31 ± 1.73 mSv. The proposed IDRLs were 14.43 mGy for CTDIvol and 357.36 mGy·cm for DLP. BMI was positively correlated with CTDIvol ( r s = 0.447 , p < 0.001) and DLP ( r s = 0.395 , p < 0.001); scan length showed the strongest association with DLP ( r s = 0.464 , p < 0.001). No significant differences in dose metrics were identified across gestational trimesters or study periods. Reference values from the 2023–2026 cohort were similar to those from the full cohort. Conclusion This study proposed IDRLs for CTPA in pregnant patients in Saudi Arabia. The findings provide local benchmarks for dose monitoring, protocol review, and future multicentre development of pregnancy-specific reference levels.
No takes yet. Share an insight, caveat, or question.
Albeshan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: